< Back | |
13 May 2022 | |
<table border=''1''><tr bgcolor=''#d6d6d6''><th class=''TTRow_left''> No.of Investor complaints pending at the beginning of the quarter </th><th class=''TTRow''> No.of Investor complaints received during the quarter</th><th class=''TTRow''> No.of Investor complaints disposed of during the quarter </th><th class=''TTRow''> No.of Investor complaints unresolved at the end of the quarter </th></tr><tr><td class=''TTRow''>0</td><td class=''TTRow''>0</td><td class=''TTRow''>0</td><td class=''TTRow''>0</td></tr></table><table border=''1''><tr><td > <span style=''font-weight:bold''>Name of the Signatory </span> </td><td> :- </td><td>Vinod Kumar Gupta</td></tr><tr><td ><span style=''font-weight:bold''>Designation </span></td><td> :- </td><td>Managing Director / Whole Time Director</td></tr></table> | |
View all announcements for PARENTERAL DRUGS (INDIA) LTD. | Source: BSE India |